Sun L - Search Results

1

Combination of Targeting Gene-ViroTherapy with 5-FU enhances antitumor efficacy in malignant colorectal carcinoma.

Qiu S, Ruan H, Pei Z, Hu B, Lan P, Wang J, Zhang Z, Gu J, Sun L, Qian C, Liu X, Qi Y. Qiu S, et al. Among authors: sun l. J Interferon Cytokine Res. 2004 Apr;24(4):219-30. doi: 10.1089/107999004323034097. J Interferon Cytokine Res. 2004. PMID: 15144568

2

Blocking HSF1 by dominant-negative mutant to sensitize tumor cells to hyperthermia.

Wang JH, Yao MZ, Gu JF, Sun LY, Shen YF, Liu XY. Wang JH, et al. Biochem Biophys Res Commun. 2002 Feb 8;290(5):1454-61. doi: 10.1006/bbrc.2002.6373. Biochem Biophys Res Commun. 2002. PMID: 11820785

3

Interleukin-2 gene has superior antinociceptive effects when delivered intrathecally.

Yao MZ, Wang JH, Gu JF, Sun LY, Liu H, Zhao ZQ, Liu XY. Yao MZ, et al. Neuroreport. 2002 May 7;13(6):791-4. doi: 10.1097/00001756-200205070-00011. Neuroreport. 2002. PMID: 11997688

4

Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter.

Liu J, Zou WG, Lang MF, Luo J, Sun LY, Wang XN, Qian QJ, Liu XY. Liu J, et al. Int J Oncol. 2002 Sep;21(3):661-6. Int J Oncol. 2002. PMID: 12168115

5

Use of Carcinoembryonic Antigen Gene Promoter in Colorectal Carcinoma-specific Suicidal Gene Therapy.

Jiang Q, Ge K, Xu DH, Sun LY, Zheng ZC, Liu XY. Jiang Q, et al. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 1998;30(1):1-8. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 1998. PMID: 12174289

6

Enhanced suicide gene therapy by chimeric tumor-specific promoter based on HSF1 transcriptional regulation.

Wang J, Yao M, Zhang Z, Gu J, Zhang Y, Li B, Sun L, Liu X. Wang J, et al. Among authors: sun l. FEBS Lett. 2003 Jul 10;546(2-3):315-20. doi: 10.1016/s0014-5793(03)00606-9. FEBS Lett. 2003. PMID: 12832060 Free article.

7

[Security of dual cancer-specific targeting vector and its cytotoxic effect when harbored].

Wang J, Gu JF, Yang SY, Xiao T, Qi R, Sun LY, Liu XY. Wang J, et al. Ai Zheng. 2006 Apr;25(4):385-92. Ai Zheng. 2006. PMID: 16613667 Chinese.

8

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.

Xu HN, Huang WD, Cai Y, Ding M, Gu JF, Wei N, Sun LY, Cao X, Li HG, Zhang KJ, Liu XR, Liu XY. Xu HN, et al. Mol Cancer. 2011 Nov 1;10:133. doi: 10.1186/1476-4598-10-133. Mol Cancer. 2011. PMID: 22040050 Free PMC article.

9

The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing.

Hu HJ, Liang X, Li HL, Du CM, Hao JL, Wang HY, Gu JF, Ni AM, Sun LY, Xiao J, Hu JQ, Yuan H, Dai YS, Jin XT, Zhang KJ, Liu XY. Hu HJ, et al. Cell Death Dis. 2020 Nov 30;11(11):1022. doi: 10.1038/s41419-020-03223-0. Cell Death Dis. 2020. PMID: 33257647 Free PMC article.

10

Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.

Hu HJ, Liang X, Li HL, Wang HY, Gu JF, Sun LY, Xiao J, Hu JQ, Ni AM, Liu XY. Hu HJ, et al. Cancer Immunol Immunother. 2021 Dec;70(12):3541-3555. doi: 10.1007/s00262-021-02946-z. Epub 2021 Apr 26. Cancer Immunol Immunother. 2021. PMID: 33903973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,182 results

Search Page

Filters